Whey Protein Targets Healthy Ageing: Agropur Highlights Sarcopenia & Cognitive Benefits
Agropur's recent webinar emphasised whey protein's role in healthy ageing, particularly for sarcopenia and cognitive health, supported by a meta-analysis showing lean mass gains from 1.2-1.59g/kg protein intake.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 11 June 2026
Whey protein ingredients are positioned as a key solution for the expanding healthy ageing demographic. Agropur's recent webinar, as reported by Food Ingredients First, highlighted scientific data and product concept innovations featuring whey for muscle, bone, cognitive, and mental health in older adults. Agropur scientists presented research advocating for specific protein intake levels to counter age-related physiological decline, alongside showcasing ingredient applications.
The demographic shift towards an older population is pronounced; World Health Organisation (WHO) statistics project that by 2030, one in six individuals will be over 60. This trend underscores the commercial imperative for the supplement industry to develop efficacious solutions for this consumer segment. Agropur's Dr. Maggie Jia cited a meta-analysis of 74 trials involving adults over 65, which concluded that consistent protein intake of 1.2–1.59 g/kg body weight per day, coupled with resistance training, significantly increases lean muscle mass. This finding directly supports product development aimed at combating sarcopenia, a condition affecting approximately 10% of the global population.
Beyond physical health, the webinar addressed cognitive and mental well-being. Emerging research suggests nutritional interventions using whey protein fractions like alpha-lactalbumin and phospholipids from milk fat globule membranes may support mental health conditions prevalent in older adults, such as depression and anxiety. This opens avenues for functional ingredients to target underdiagnosed mental health challenges within the ageing population.
Agropur also unveiled various product concepts, demonstrated by application scientist Amy O’ Keefe. These included immunity-boosting juice, sleep-aid gummies and milk tea, and instant pudding designed for mental well-being, all formulated with Agropur’s whey ingredients such as BiPRO 9500, ISO Chill 9000, BiPRO Alpha 9000, ISO Chill 8010/8011, and ISO Chill 6000. These diverse applications illustrate the versatility of whey across multiple product formats to meet diverse consumer preferences in the healthy ageing market.
What this means for United Kingdom
UK brand owners must leverage the scientific backing for whey protein to justify premium pricing and product claims specifically targeting the healthy ageing market. Retailers like Boots and Holland & Barrett will favour products with clear efficacy data, especially for sarcopenia prevention. Formulators should focus on delivering 1.2-1.59g/kg daily protein doses in accessible formats. Compliance with FSA and EFSA regulations on health claims for protein-muscle health is critical, requiring robust evidence like the meta-analysis cited. Competitive opportunities exist in developing novel formats such as functional gummies or specialised beverages that integrate advanced whey fractions for cognitive and mood support.
Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.